To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
119-hr679 — To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.. Sponsored by Rep. Harshbarger, Diana [R-TN-1]. Introduced 2025-01-23. House bill. 119th Congress. Latest action: Referred to the House Committee on Energy and Commerce.
Bill Activity
House
Introduced
Introduced in House
Introduced in House
2025-01-23
Referred to Committee
Referred to the House Committee on Energy and Commerce.
- Sponsor
- Rep. Harshbarger, Diana [R-TN-1] (R), TN
- Introduced
- 2025-01-23
- Committees
- Energy and Commerce Committee
- Subjects
- Abortion; Drug safety, medical device, and laboratory regulation; Drug therapy; Prescription drugs
- Latest Action
- Referred to the House Committee on Energy and Commerce.
No roll-call vote data available for this bill.
Explore This Bill
Investigate this bill → AI summary, roll-call breakdown, and full bill analysis